Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Aastrom Biosciences awarded two NIH grants; begins phase I trial of UCB transplants

Oct. 8, 1997

Cell Genesys reports development of second-generation lentiviral gene delivery system

Oct. 8, 1997

NIH contemplates licensing liposomal delivery technology to Biovector Therapeutics

Oct. 7, 1997

Sequana receives Phase I SBIR grant for RAMMP technology

Oct. 7, 1997

SDD drug delivery system available for licensing from Bioglan

Oct. 6, 1997

Genetronics receives NCI grant for electroporation research

Oct. 2, 1997

Allergan and Acadia enter drug discovery collaboration

Sep. 29, 1997

Baxter and Inhale commence phase II trial using pulmonary delivery system

Sep. 26, 1997

Cel-Sci and NCI collaborate on immunotherapy research for cancer

Sep. 26, 1997

Darwin Molecular and Geron investigate gene for premature aging

Sep. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...